Investor Stock List
Ranked #7,317 of 8,699 institutional investors

PSP Research LLC

Las Vegas, NV

$139M
US stock portfolio at live prices · today −$425K (−0.30%)
Market closed. Prices as of Nov 20, 8:11 AM ET
Value at quarter end (Q3 2026)
$146M
Change from Q2 2026
−$42.1M (−22.38%)
Positions
39 · 1 new, 27 sold out
Filed
Oct 21, 2026

Not counted in the ranking: none$1.3M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
SGOV 50.6%XBI 40.0%SERA 3.25%EXEL 0.24%TGTX 0.23%
StockSharesValue, live% of portfoliovs Q2 2026
SGOV iShares 0-3 Month Treasury Bond ETF700,000$70.4M50.6%Unchanged
XBI State Street SPDR S&P Biotech ETF386,500$55.7M40.0%Reduced −32%
SERA Sera Prognostics, Inc.2,396,685$4.5M3.25%New
EXEL Exelixis, Inc.5,000$329K0.24%Reduced −38%
TGTX TG Therapeutics, Inc.5,000$324K0.23%Reduced −50%
ORKA Oruka Therapeutics, Inc.3,000$293K0.21%Unchanged
ARGX argenx SE300$283K0.20%Reduced −53%
NBIX Neurocrine Biosciences, Inc.1,800$282K0.20%Reduced −40%
HALO Halozyme Therapeutics, Inc.3,000$279K0.20%Reduced −57%
TARS Tarsus Pharmaceuticals, Inc.3,500$272K0.20%Reduced −50%
ARQT Arcutis Biotherapeutics, Inc.10,000$272K0.20%Reduced −49%
STOK Stoke Therapeutics, Inc.9,000$242K0.17%Reduced −25%
KYMR Kymera Therapeutics, Inc.2,000$239K0.17%Reduced −50%
MIRM Mirum Pharmaceuticals, Inc.2,500$239K0.17%Unchanged
MDGL Madrigal Pharmaceuticals, Inc.600$238K0.17%Unchanged
INCY Incyte Corporation2,000$232K0.17%Reduced −62%
HRMY Harmony Biosciences Holdings, Inc.7,000$231K0.17%Reduced −30%
IMVT Immunovant, Inc.7,000$228K0.16%Reduced −46%
TNGX Tango Therapeutics, Inc.10,000$227K0.16%Unchanged
AUPH Aurinia Pharmaceuticals Inc.15,000$223K0.16%Reduced −50%
KRYS Krystal Biotech, Inc.692$219K0.16%Unchanged
DNTH Dianthus Therapeutics, Inc.2,500$212K0.15%Unchanged
EWTX Edgewise Therapeutics, Inc.5,000$206K0.15%Unchanged
TRVI Trevi Therapeutics, Inc.15,000$206K0.15%Reduced −50%
IMNM Immunome, Inc.12,000$199K0.14%Reduced −33%
DFTX Definium Therapeutics, Inc.6,500$192K0.14%Reduced −35%
RVMD Revolution Medicines, Inc.1,200$191K0.14%Unchanged
NTLA Intellia Therapeutics, Inc.20,000$190K0.14%Unchanged
IMCR Immunocore Holdings plc7,000$186K0.13%Reduced −54%
PTGX Protagonist Therapeutics, Inc.1,500$186K0.13%Reduced −50%
NRIX Nurix Therapeutics, Inc.12,000$163K0.12%Reduced −52%
DYN Dyne Therapeutics, Inc.10,000$160K0.12%Reduced −50%
SNDX Syndax Pharmaceuticals, Inc.12,000$110K<0.1%Reduced −40%
ORIC ORIC Pharmaceuticals, Inc.13,000$100K<0.1%Unchanged
ARDX Ardelyx, Inc.30,000$92K<0.1%Reduced −50%
OCUL Ocular Therapeutix, Inc.15,000$88K<0.1%Unchanged
CMPS COMPASS Pathways plc10,000$87K<0.1%Reduced −44%
CTMX CytomX Therapeutics, Inc.39,400$81K<0.1%Unchanged
OLMA Olema Oncology, Inc.10,000$72K<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
IRON Disc Medicine, Inc.8,000$609K
KOD Kodiak Sciences Inc.6,000$587K
SYRE Spyre Therapeutics, Inc.4,000$391K
CLDX Celldex Therapeutics, Inc.13,000$363K
PTCT PTC Therapeutics, Inc.6,000$350K
ACAD Acadia Pharmaceuticals Inc.19,766$348K
COGT Cogent Biosciences, Inc.12,000$333K
RAPP Rapport Therapeutics, Inc.14,000$330K
ELVN Enliven Therapeutics, Inc.7,000$325K
RARE Ultragenyx Pharmaceutical Inc.17,000$293K
AMLX Amylyx Pharmaceuticals, Inc.10,838$284K
LQDA Liquidia Corporation5,000$283K
ZYME Zymeworks Inc.10,000$269K
VKTX Viking Therapeutics, Inc.10,000$258K
BBIO BridgeBio Pharma, Inc.3,000$235K
RYTM Rhythm Pharmaceuticals, Inc.2,000$234K
ALNY Alnylam Pharmaceuticals, Inc.1,465$217K
GLUE Monte Rosa Therapeutics, Inc.23,000$205K
SRRK Scholar Rock Holding Corporation3,827$193K
VERA Vera Therapeutics, Inc.7,000$187K
IONS Ionis Pharmaceuticals, Inc.6,800$185K
XENE Xenon Pharmaceuticals Inc.4,200$158K
DNLI Denali Therapeutics Inc.8,463$154K
AXSM Axsome Therapeutics, Inc.1,000$136K
ARWR Arrowhead Pharmaceuticals, Inc.2,600$113K
AVBP ArriVent BioPharma, Inc.7,041$79K
EYPT EyePoint, Inc.10,000$3K